Toxicokinetics of naringin, a putative antitussive, after 184-day repeated oral administration in rats

Environmental Toxicology and Pharmacology

Volumn 31, Issue 3, 2011, Pages 485-489

  Liu, Menghua ^a   Yang, Cuiping ^a   Zou, Wei ^a   Guan, Xiaoling ^b   Zheng, Wenyan ^a   Lai, Li ^b   Fang, Siqi ^a   Cai, Shuxing ^a   Su, Weiwei ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b National Chengdu Center for Safety Evaluation of Drugs   (China)

Author keywords

Naringenin; Naringin; Rats; Toxicokinetics

Indexed keywords

ANTITUSSIVE AGENT; AURANTIIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG SAFETY; FEMALE; FOOD INTAKE; LIQUID CHROMATOGRAPHY; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PUMMELO; RAT; REPEATED DRUG DOSE; SEX DIFFERENCE; TANDEM MASS SPECTROMETRY; TIME TO MAXIMUM PLASMA CONCENTRATION; TOXICITY TESTING; TOXICOKINETICS;

ADMINISTRATION, ORAL; ANIMALS; ANTITUSSIVE AGENTS; AREA UNDER CURVE; BEHAVIOR, ANIMAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EATING; FEMALE; FLAVANONES; MALE; MASS SPECTROMETRY; RATS; RATS, SPRAGUE-DAWLEY;

CITRUS MAXIMA; RATTUS;

EID: 79954731608     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etap.2011.01.006     Document Type: Article

References (19)

1. Chen Y.T., Zheng R.L., Jia Z.J., Ju Y. Flavonoids as superoxide scavengers and antioxidants. Free Radic. Biol. Med. 1990, 9:19-21.
2. Fang T.Z., Wang Y.G., Ma Y., Su W.W., Bai Y., Zhao P.Y. A rapid LC/MS/MS quantitation assay for naringin and its two metabolites in rats plasma. J. Pharm. Biomed. Anal. 2006, 40:454-459.
3. Felgines C., Texier O., Morand C., Manach C., Scalbert A., Régerat F., Rémésy C. Bioavailability of the flavanone naringenin and its glycosides in rats. Am. J. Physiol. Gastrointest. Liver Physiol. 2000, 279:1148-1154.
4. Gao S., Li P.B., Yang H.L., Fang S.Q., Su W.W. Antitussive effect of naringin on experimentally induced cough in guinea pigs. Planta Med. 2010, doi:10.1055/s-0030-1250117.
5. Hsiu S.L., Huang T.Y., Hou Y.C., Chin D.H., Lee Chao P.D. Comparison of metabolic pharmacokinetics of naringin and naringenin in rabbits. Life Sci. 2002, 70:1481-1489.
6. Ishii K., Furuta T., Kasuya Y. Determination of naringin and naringenin in human plasma by high-performance liquid chromatography. J. Chromatogr. B 1996, 683:225-229.
7. Ishii K., Furuta T., Kasuya Y. Determination of naringin and naringenin in human urine by high-performance liquid chromatography utilizing solid-phase extraction. J. Chromatogr. B 1997, 704:299-305.
8. Lambev I., Krushkov I., Zheliazkov D., Nikolov N. Antiexudative effect of naringin in experimental pulmonary edema and peritonitis. Eksp. Med. Morfol. 1980, 19:207-212.
9. Lee C.H., Jeong T.S., Choi Y.K., Hyun B.H., Oh G.T., Kim E.H., Kim J.R., Han J.I., Bok S.H. Anti-atherogenic effect of citrus flavonoids, naringin and naringenin, associated with hepatic ACAT and aortic VCAM-1 and MCP-1 in high cholesterol-fed rabbits. Biochem. Biophys. Res. Commun. 2001, 284:681-688.
10. Li X.H., Xiong Z.L., Lu S., Zhang Y., Li F.M. Pharmacokinetics of naringin and its metabolite naringenin in rats after oral administration of Rhizoma drynariae extract assayed by UPLC-MS/MS. Chinese J. Nat. Med. 2010, 8(1):40-46.
11. Li X.L., Xiao H.B., Liang X.M., Shi D.Z., Liu J.G. LC-MS/MS determination of naringin, hesperidin and neohesperidin in rat serum after orally administrating the decoction of Bulpleurum falcatum L. and Fractus aurantii. J. Pharm. Biomed. Anal. 2004, 34:159-166.
12. Martin M.J., Marhuenda F., Perez-Guerrero C., Franco J.M. Antiulcer effect of naringin on gastric lesions induced by ethanol in rats. Pharmacology 1994, 49:144-150.
13. Mata-Bilbao M., de L., Andrés-Lacueva C., Roura E., Jáuregui O., Escribano E., Torre C., Lamuela-Raventós R.M. Absorption and pharmacokinetics of grapefruit flavanones in beagles. Brit. J. Nutr. 2007, 98:86-92.
14. Schindler R., Mentlein R. Flavonoids and Vitamin E reduce the release of the angiogenic peptide vascular endothelial growth factor from human tumor cells. J. Nutr. 2006, 136:1477-1482.
15. Serra H., Mendes T., Bronze M.R., Luísa Simplíci Ana. Prediction of intestinal absorption and metabolism of pharmacologically active flavones and flavanones. Bioorgan. Med. Chem. 2008, 16:4009-4018.
16. Su C., Wong K.L., But P.-H.P., Su W.W., Shaw P.C. Molecular authentication of the Chinese Herb Huajuhong and related medicinal material by DNA sequencing and ISSR markers. J. Food Drug Anal. 2010, 18:161-170.
17. Su, W.W., Wang, Y.G., Fang, T.Z., Peng, W., Wu, Z., 2009. Uses of naringenin, naringin and salts thereof as expectorants in the treatment of cough, and compositions thereof. European Patent 1591123.
18. Sun N., Lu G.C., Lin M., Fan G.R., Wu Y.T. Subchronic toxicity and toxicokinetics of MCC-555, a novel thiazolidinedione, after 270-day repeated oral administration in dogs. Environ. Toxicol. Pharmacol. 2009, 27:237-246.
19. Wang M.J., Lee Chao P.D., Hou Y.C., Hsiu S.L., Wen K.C., Tsai S.Y. Pharmacokinetics and conjugation metabolism of naringin and naringenin in rats after single dose and multiple dose administration. J. Food Drug Anal. 2006, 14:247-253.